Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Daeduck Electronics (353200) – Advance Notice of Earnings Release (Information Disclosure) / 2024-10-17 Semiconductors
  • [Disclosure] Hanwha Systems (272210) – Sales/Supply Contract / 2024-03-27 Disclosures
  • [Disclosure] Hana Micron (067310) – Investor Relations (IR) Holding / 2025-08-27 Semiconductors
  • [Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P13 SC in South Korea (Pediatric Ulcerative Colitis) / 2024-09-30 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Decision on Record Date for Cash and Property Dividend / 2025-07-24 Disclosures
  • [Research] SK hynix (000660 / SKHY) – Kiwoom | Commodity Memory Pricing · Supply Constraints · Earnings Surge / 2026-05-11 RESEARCH
  • [Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan for CT-P13 SC (Zymfentra) in Europe (Part 1 & 2) (Rheumatoid Arthritis Patients) / 2024-12-17 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Trading Suspension and Resumption of Stock Futures / 2024-04-05 Disclosures

[Disclosure] Hanmi Semiconductor (042700) – Decision on Treasury Stock Acquisition Trust Agreement / 2024-04-23

Posted on April 23, 2024August 1, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Hanmi Semiconductor has decided to enter into a KRW 50B treasury stock acquisition trust agreement with Samsung Securities to stabilize its stock price and enhance shareholder value.

📊 [Key Disclosure Details & Financial Figures Summary]

  1. Trust Agreement Details & Amount
  • Contract Amount: KRW 50,000,000,000 (KRW 50B)
  • Contract Period: April 23, 2024 ~ October 23, 2024
  • Purpose of Contract: Enhancing shareholder value through stock price stabilization
  • Contracting Institution & Broker: Samsung Securities Co., Ltd.
  • Scheduled Contract Date: April 23, 2024
  1. Treasury Stock Holdings Prior to Agreement
  • Common Stock Quantity: 859,600 shares (Trustee Holdings: 341,600 shares + Physical Holdings: 518,000 shares)
  • Shareholding Ratio: 0.88%
  1. Treasury Stock Acquisition Limit Calculation
  • Dividend Limit Subtotal (as of Dec 31, 2023, Separate Financial Statements): KRW 304,763,919,009 (Net Assets KRW 591,726,363,200 – Capital Stock KRW 12,716,420,500 – Capital/Profit Reserves KRW 62,740,283,188 – Unrealized Profits KRW 211,505,740,503)
  • Dividends & Reserves Approved at Annual General Meeting: KRW 40,521,474,840
  • Existing Trust Agreement Amount: KRW 20,000,000,000
  • Maximum Limit for Treasury Stock Acquisition: KRW 244,242,444,169
  1. Board Resolution & Other Details
  • Board Resolution Date: April 23, 2024 (1 Outside Director attended, Statutory Auditor attended)

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Actual Treasury Stock Share Purchases Under the Trust Agreement

This disclosure announces the decision to enter into a KRW 50B trust agreement to acquire treasury stock through a trustee institution. Confirming the actual volume and execution of share purchases within the contract amount during the agreement period is important for understanding the implementation of the company’s shareholder return policy. The actual acquisition details and progress can be verified in upcoming periodic disclosures (such as Quarterly Reports, Semiannual Reports, or Annual Reports) under the treasury stock status section or through subsequent public filings regarding the trust agreement.

📢 Disclaimer and Source Notice

Source: This content was newly structured and created based on officially submitted data from the Data Analysis, Retrieval and Transfer System (DART) of the Financial Supervisory Service.

Investment Risk Warning: This content is provided solely for informational and language reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities lie entirely with the individual investor.

Contact: For inquiries regarding compliance or copyright issues, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Semiconductors, Disclosures

Post navigation

Previous Post: [Disclosure] Hanwha Systems (272210) – Corporate Investor Relations (IR) Announcement / 2024-04-23
Next Post: [Disclosure] Hanwha Ocean (042660) – Consolidated Financial Results (Provisional) / 2024-04-24

Related Posts

  • [Disclosure] ISU PETASYS (007660) – Decision on Calling of General Meeting of Shareholders / 2024-03-08 Semiconductors
  • [Disclosure] ISU PETASYS (007660) – Clarification on Rumors or News Reports (Unconfirmed) / 2025-01-02 Semiconductors
  • [Disclosure] ISU PETASYS(007660) – Investor Relations (IR) Holding Announcement / 2025-09-11 Semiconductors
  • [Disclosure] Celltrion (068270) – Single Sales / Supply Contract / 2026-03-17 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Corporate Value-up Plan (Voluntary Disclosure) / 2026-03-19 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – Investor Relations (IR) Holding Announcement / 2024-04-17 Disclosures
  • [Disclosure] LEENO Industrial (058470) – Decision on Cash/In-Kind Dividend / 2024-12-19 Semiconductors
  • [Disclosure] Wonik IPS (240810) – Decision on Calling of General Shareholders’ Meeting / 2026-02-25 Semiconductors
  • [Disclosure] ALTEOGEN (196170) – Investor Relations (IR) Holding / 2025-02-14 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Correction of Decision on Debt Guarantee for Others / 2024-12-20 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Clarification on Rumors or Reports (Unconfirmed) / 2024-02-28 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Pre-announcement of Financial Results Disclosure / 2024-07-18 Disclosures
  • [Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P55 (Cosentyx Biosimilar) in the U.S. / 2024-07-01 Disclosures
  • [Disclosure] Hana Micron (067310) – Investor Relations (IR) Meeting / 2026-05-20 Semiconductors

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme